Positive phase III data for Roche’s Gazyva/Gazyvaro show significant reduction in disease activity for systemic lupus erythematosus
Basel, 3 November 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today statistically significant and clinically meaningful results from the phase III ALLEGORY study of Gazyva®/Gazyvaro® (obinutuzumab) in adults with systemic lupus erythematosus (SLE) on standard therapy. The study met its primary endpoint showing a higher percentage of people achieved a minimum four-point improvement […]
India and New Zealand Begin Fourth Round of Free Trade Agreement Negotiations
The Fourth Round (November 3-7, 2025) of negotiations for the India-New Zealand Free Trade Agreement (FTA) commenced today in Auckland, New Zealand marking another step forward in advancing a balanced, comprehensive, and mutually beneficial partnership between the two nations. This development builds on the shared commitment to deepen economic ties and guidance given by Hon’ble […]
Roche to present new data from its broad and innovative haematology portfolio at ASH 2025
Basel, 3 November 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will showcase 46 abstracts, including 12 oral presentations, from its industry-leading haematology portfolio at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, held 6-9 December 2025 in Orlando, Florida, US. “The data we will present at this year’s […]
WHO calls for a new era of strategic urban health action with global guide to unlock healthy, prosperous and resilient societies
https://www.who.int/news/item/31-10-2025-who-calls-for-a-new-era-of-strategic-urban-health-action-with-global-guide-to-unlock-healthy-prosperous-and-resilient-societies Geneva----On World Cities Day, the World Health Organization (WHO) calls on national and city leaders to transform urban areas into engines of health, equity and sustainability. More than 4.4 billion people, over half of humanity, now live in urban areas, a figure projected to rise to nearly 70% by 2050. In cities health, inequality, environment […]
Multi-country outbreak of mpox, External situation report #59 - 30 October 2025
OVERVIEW This is the 59th situation report for the multi-country outbreak of mpox, which provides details on the global epidemiological situation for mpox, including an update on the epidemiological situation with data on the global situation as of 30 September 2025, in Africa as of 19 October and the operational response updates as of 24 […]
Roche purchases shares in tender offer for 89bio, Inc
Basel, 30 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Roche’s wholly owned subsidiary Bluefin Merger Subsidiary, Inc., has accepted for payment all shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common stock of 89bio, Inc. (“89bio”, NASDAQ: ETNB) at a price […]
WHO condemns killings of patients and civilians amid escalating violence in El Fasher, Sudan
https://www.who.int/news/item/29-10-2025-who-condemns-killings-of-patients-and-civilians-amid-escalating-violence-in-el-fasher--sudan Geneva/Cairo---The World Health Organization (WHO) condemns the reported killing of more than 460 patients and their companions, as well as the abduction of six health workers, on 28 October from the Saudi Maternity Hospital in El Fasher. This latest tragedy is taking place in the rapidly worsening crisis in North Darfur’s El Fasher, […]
Climate inaction is claiming millions of lives every year, warns new Lancet Countdown report
GENEVA, 29 October 2025, WHO and global partners are calling for the protection of people’s health to be recognized as the most powerful driver of climate action, as a new global report released today warns that continued overreliance on fossil fuels and failure to adapt to a heating world are already having a devastating toll […]
Roche receives CE mark for novel automated high-throughput Elecsys Dengue Ag test to diagnose dengue
Basel, 29 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received CE mark for its Elecsys® Dengue Ag test – a high-throughput, fully automated immunoassay to be used as an aid in the diagnosis of an acute dengue virus infection. This milestone promises to set a new standard for […]
Positive phase III results for Roche’s Gazyva/Gazyvaro in children and young adults with idiopathic nephrotic syndrome
Basel, 28 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today statistically significant and clinically meaningful results from the phase III INShore study of Gazyva®/Gazyvaro® (obinutuzumab) in children and young adults (aged >= 2-25 years) with idiopathic nephrotic syndrome (INS). The study met its primary endpoint, with more people achieving sustained complete remission […]
